These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2408698)

  • 1. Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart.
    Ferry DR; Glossmann H; Kaumann AJ
    Br J Pharmacol; 1985 Apr; 84(4):811-24. PubMed ID: 2408698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular approach to the calcium channel.
    Glossmann H; Ferry DR; Goll A; Linn T
    Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between beta-adrenoceptors and calcium channels in human ventricular myocardium.
    Ferry DR; Kaumann AJ
    Br J Pharmacol; 1987 Mar; 90(3):447-57. PubMed ID: 2436700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
    Bellemann P
    J Recept Res; 1984; 4(1-6):571-85. PubMed ID: 6084713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.
    Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F
    Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes.
    Carvalho CA; Coutinho OP; Carvalho AP
    J Neurochem; 1986 Dec; 47(6):1774-84. PubMed ID: 2430061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine.
    Glossmann H; Ferry DR
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Aug; 323(4):279-91. PubMed ID: 6314149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of [3H]nifedipine binding sites in rabbit myocardium.
    Holck M; Thorens S; Haeusler G
    Eur J Pharmacol; 1982 Dec; 85(3-4):305-15. PubMed ID: 6295786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of putative calcium channels in skeletal muscle microsomes.
    Ferry DR; Glossmann H
    FEBS Lett; 1982 Nov; 148(2):331-7. PubMed ID: 6295810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
    Goll A; Ferry DR; Striessnig J; Schober M; Glossmann H
    FEBS Lett; 1984 Oct; 176(2):371-7. PubMed ID: 6092142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel antagonist binding sites labeled by 3H-nimodipine in human brain.
    Peroutka SJ; Allen GS
    J Neurosurg; 1983 Dec; 59(6):933-7. PubMed ID: 6631515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding properties of a novel calcium channel activating dihydropyridine in monolayer cultures of beating myocytes.
    Bellemann P
    FEBS Lett; 1984 Feb; 167(1):88-92. PubMed ID: 6199232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter.
    Striessnig J; Zernig G; Glossmann H
    Eur J Biochem; 1985 Jul; 150(1):67-77. PubMed ID: 2990927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of binding of a calcium channel blocker to inhibition of contraction in intact cultured embryonic chick ventricular cells.
    Marsh JD; Loh E; Lachance D; Barry WH; Smith TW
    Circ Res; 1983 Oct; 53(4):539-43. PubMed ID: 6313249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of multiple receptor sites within the putative calcium channel.
    Ferry DR; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Oct; 321(1):80-3. PubMed ID: 6292744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand.
    Ferry DR; Goll A; Glossmann H
    Biochem J; 1987 Apr; 243(1):127-35. PubMed ID: 2440422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of voltage operated calcium channels by binding studies: differentiation of subclasses of calcium antagonist drugs with 3H-nimodipine radioligand binding.
    Glossmann H; Ferry DR; Lübbecke F; Mewes R; Hofmann F
    J Recept Res; 1983; 3(1-2):177-90. PubMed ID: 6304295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.